Allergic ocular diseases are mediated primarily by mast cells but also
by lymphocytes. A wide variety of therapeutic agents are available; t
heir appropriate usage depends both upon an accurate diagnosis as well
as on an understanding of their mechanisms of action and side effects
. Many promising new oral and topical agents for the treatment of ocul
ar allergic disease are currently under investigation.